RDEA119

URI: https://gptkb.org/entity/RDEA119
GPTKB entity
Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkb:drug
gptkbp:ATCCode none
gptkbp:CASNumber 923032-37-5
gptkbp:clinicalTrialPhase Phase II
gptkbp:developedBy gptkb:Bayer
gptkb:cancer
gptkb:Ardea_Biosciences
gptkbp:hasMolecularFormula C16H13ClF2N2O3S
gptkbp:hasUNII 6QX8J8QK1U
gptkbp:mechanismOfAction gptkb:MEK_inhibitor
gptkbp:molecularWeight 402.8 g/mol
gptkbp:PubChem_CID gptkb:CHEMBL2105727
25154816
gptkbp:routeOfAdministration oral
gptkbp:status gptkb:investigational_drug
gptkbp:synonym gptkb:refametinib
gptkb:BAY_86-9766
gptkbp:target gptkb:MEK1
gptkb:MEK2
gptkbp:bfsParent gptkb:refametinib
gptkbp:bfsLayer 7
https://www.w3.org/2000/01/rdf-schema#label RDEA119